Neurogene Inc. SEC filings NGNE
Neurogene Inc. has 750 filings in SEC EDGAR's recent list, going back to Jun 25, 2007. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 6, 2026 | — |
| 4 | Insider transaction | Oct 2, 2026 | Sep 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2026 | Jun 30, 2026 |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| 424B5 | Prospectus supplement | Jun 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 4/A | Form 4/a | Jun 16, 2026 | Jan 16, 2024 |
| 4/A | Form 4/a | Jun 16, 2026 | Jun 14, 2024 |
| 4/A | Form 4/a | Jun 16, 2026 | Jun 12, 2025 |
| 3/A | Form 3/a | Jun 16, 2026 | Dec 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 144 | Notice of proposed sale | May 6, 2026 | — |
| 3 | Initial insider ownership | Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 26, 2026 |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 144 | Notice of proposed sale | Mar 13, 2026 | — |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2025 | Oct 9, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 424B5 | Prospectus supplement | Aug 11, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 14, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 144 | Notice of proposed sale | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 14, 2025 | Apr 14, 2025 |
| EFFECT | Filing | Apr 4, 2025 | — |
| CORRESP | Letter to the SEC | Apr 2, 2025 | — |
| 424B3 | Prospectus | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| EFFECT | Filing | Mar 28, 2025 | — |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| S-3 | Shelf registration | Mar 24, 2025 | — |
| POS AM | Filing | Mar 24, 2025 | — |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 424B3 | Prospectus | Dec 18, 2024 | — |
| EFFECT | Filing | Dec 16, 2024 | — |
| CORRESP | Letter to the SEC | Dec 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2024 | — |
| S-1 | Registration statement | Dec 2, 2024 | — |
| 4 | Insider transaction | Nov 27, 2024 | Nov 26, 2024 |
| 3 | Initial insider ownership | Nov 27, 2024 | Nov 25, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 27, 2024 | — |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 21, 2024 | Nov 20, 2024 |
| 10-Q | Quarterly report | Nov 18, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 18, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2024 | Nov 11, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2024 | Aug 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Jul 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2024 | Apr 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 144 | Notice of proposed sale | Mar 7, 2024 | — |
| 144 | Notice of proposed sale | Mar 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2024 | Feb 15, 2024 |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 144 | Notice of proposed sale | Feb 9, 2024 | — |
| 144 | Notice of proposed sale | Feb 6, 2024 | — |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 4 | Insider transaction | Jan 18, 2024 | Jan 16, 2024 |
| 3 | Initial insider ownership | Jan 18, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Dec 27, 2023 | — |
| 3 | Initial insider ownership | Dec 26, 2023 | Dec 18, 2023 |
| 3 | Initial insider ownership | Dec 26, 2023 | Dec 18, 2023 |
| 3 | Initial insider ownership | Dec 26, 2023 | Dec 18, 2023 |
| 3 | Initial insider ownership | Dec 26, 2023 | Dec 18, 2023 |
| 3 | Initial insider ownership | Dec 26, 2023 | Dec 18, 2023 |
| 3 | Initial insider ownership | Dec 26, 2023 | Dec 18, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 22, 2023 | — |
| SC 13D | Ownership over 5% (active) | Dec 21, 2023 | — |
| 4 | Insider transaction | Dec 20, 2023 | Dec 18, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 20, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Dec 19, 2023 | Dec 13, 2023 |
| 425 | Filing | Dec 6, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 425 | Filing | Dec 4, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 4, 2023 | Nov 30, 2023 |
| 425 | Filing | Nov 30, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| SEC STAFF LETTER | Filing | Nov 13, 2023 | — |
| EFFECT | Filing | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 8, 2023 | — |
| CORRESP | Letter to the SEC | Nov 8, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NGNE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1404644
- Former names
- Neoleukin Therapeutics, Inc. (until Dec 6, 2023); AQUINOX PHARMACEUTICALS, INC (until Aug 12, 2019); AQUINOX PHARMACEUTICALS (USA) INC (until Dec 24, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.